These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36405526)

  • 1. An Analysis of the COVID-19 Situation in India in Terms of Testing, Treatment, Vaccine Acceptance and National Economic Performance.
    Patel RB; Patel BB
    Int J Public Health; 2022; 67():1604975. PubMed ID: 36405526
    [No Abstract]   [Full Text] [Related]  

  • 2. A Cross-sectional Survey of Public Knowledge and Perspective on Coronavirus Disease, Vaccination, and Related Research in India during the COVID-19 Pandemic.
    Munshi R; Maurya M
    J Assoc Physicians India; 2023 Sep; 71(9):19-27. PubMed ID: 38700297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Incidence Proportion as a Function of Regional Testing Strategy, Vaccination Coverage, and Vaccine Type.
    Totolian AA; Smirnov VS; Krasnov AA; Ramsay ES; Dedkov VG; Popova AY
    Viruses; 2023 Oct; 15(11):. PubMed ID: 38005859
    [No Abstract]   [Full Text] [Related]  

  • 4. The impact of geo-political socio-economic factors on vaccine dissemination trends: a case-study on COVID-19 vaccination strategies.
    Chauhan R; Varma G; Yafi E; Zuhairi MF
    BMC Public Health; 2023 Nov; 23(1):2142. PubMed ID: 37919737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation.
    Sandmann FG; Davies NG; Vassall A; Edmunds WJ; Jit M;
    Lancet Infect Dis; 2021 Jul; 21(7):962-974. PubMed ID: 33743846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of the India COVID-19 vaccine tracker.
    Singh H; Lohia R; George LS; Gupta N; Thangaraj JW; Rana S; Rana S; Kaur J; Shivam S; Arora NK; Muliyil JP; Murhekar MV; Lodha R; Pandey RM; Rao VV; Dhandore S; Malik A; Kumar V; Tripathi A; Panda S; Bhargava B
    Indian J Med Res; 2022; 155(5&6):513-517. PubMed ID: 35859397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of COVID-19 Vaccine Hesitancy: A Cross-Sectional Study on a Mexican Population Using an Online Questionnaire (COV-AHQ).
    Delgado-Gallegos JL; Padilla-Rivas GR; Zúñiga-Violante E; Avilés-Rodríguez G; Arellanos-Soto D; Gastelum-Arias LJ; Franco Villareal H; Cosío-León MLÁ; Romo-Cardenas GS; Moreno-Treviño MG; Moreno-Cuevas JE; Islas JF
    Front Public Health; 2021; 9():728690. PubMed ID: 34900890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Influencing COVID-19 Vaccination Intentions Among College Students: A Cross-Sectional Study in India.
    Jain L; Vij J; Satapathy P; Chakrapani V; Patro B; Kar SS; Singh R; Pala S; Sankhe L; Modi B; Bali S; Rustagi N; Rajagopal V; Kiran T; Goel K; Aggarwal AK; Gupta M; Padhi BK
    Front Public Health; 2021; 9():735902. PubMed ID: 34976911
    [No Abstract]   [Full Text] [Related]  

  • 9. Status of COVID-19 vaccination around South Asia.
    Hayat M; Uzair M; Ali Syed R; Arshad M; Bashir S
    Hum Vaccin Immunother; 2022 Dec; 18(1):2016010. PubMed ID: 35061956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 vaccination in Nigeria: A rapid review of vaccine acceptance rate and the associated factors.
    Olu-Abiodun O; Abiodun O; Okafor N
    PLoS One; 2022; 17(5):e0267691. PubMed ID: 35544545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global landscape of COVID-19 vaccination progress: insight from an exploratory data analysis.
    Dey SK; Rahman MM; Siddiqi UR; Howlader A; Tushar MA; Qazi A
    Hum Vaccin Immunother; 2022 Dec; 18(1):2025009. PubMed ID: 35050838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is COVID-19 vaccine inequality undermining the recovery from the COVID-19 pandemic?
    Suárez-Álvarez A; López-Menéndez AJ
    J Glob Health; 2022 May; 12():05020. PubMed ID: 35604879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Traditional Vaccine Development Strategies to SARS-CoV-2.
    Rando HM; Lordan R; Lee AJ; Naik A; Wellhausen N; Sell E; Kolla L; ; Gitter A; Greene CS
    mSystems; 2023 Apr; 8(2):e0092722. PubMed ID: 36861991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 Vaccine: A comprehensive status report.
    Kaur SP; Gupta V
    Virus Res; 2020 Oct; 288():198114. PubMed ID: 32800805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the safety and efficacy of current COVID-19 vaccines.
    Huang Z; Su Y; Zhang T; Xia N
    Front Med; 2022 Feb; 16(1):39-55. PubMed ID: 35122210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms.
    Jafari A; Danesh Pouya F; Niknam Z; Abdollahpour-Alitappeh M; Rezaei-Tavirani M; Rasmi Y
    Mol Biol Rep; 2022 Jun; 49(6):4943-4957. PubMed ID: 35235159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Media Reporting Relating to COVID-19 Vaccination as a Driver of Vaccine Hesitancy Prior to the Second Wave of the COVID-19 Pandemic in India: A Content Analysis of Newspaper and Digital Media Reports.
    Basu S; Sharma H
    Cureus; 2023 Mar; 15(3):e36750. PubMed ID: 37123709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review.
    Krishnaratne S; Pfadenhauer LM; Coenen M; Geffert K; Jung-Sievers C; Klinger C; Kratzer S; Littlecott H; Movsisyan A; Rabe JE; Rehfuess E; Sell K; Strahwald B; Stratil JM; Voss S; Wabnitz K; Burns J
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013812. PubMed ID: 33331665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.